The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Apr 23, 2025

Keywords

ClinConnect Summary

This clinical trial is looking into the status and trends of hepatitis C virus (HCV) infection among pregnant women in Xi'an, China, over the past ten years. The goal is to better understand how HCV affects pregnant women and to find ways to improve care and prevention strategies for them. By studying this issue, researchers hope to support better health outcomes for mothers and their babies.

To participate in this trial, women need to be at least 18 years old and either currently pregnant or recently given birth, with confirmed HCV infection based on blood tests conducted between 2014 and 2023. Participants should have a valid phone number, as it will be used for communication about the study. It's important to note that the trial is not yet recruiting participants, so women who meet these criteria will need to wait for further announcements. This research aims to make a significant impact on how HCV is managed in pregnant women, ultimately leading to healthier pregnancies and newborns.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Pregnant women or parturient women confirmed by blood HCG test.
• • 2. Patients aged 18 years old and above.
• • 3. Patients with HCV antibody seropositive or HCV RNA positive from 2014-2023.
• Exclusion Criteria:
• • 1. Patients without valid telephone numbers.
• • 2. Duplicate records: For duplicate records of the same pregnant woman, only one record should be kept.